Comparing the cost-effectiveness of treatments for blood clots in cancer patients

Research conducted by UC Davis Comprehensive Cancer Center and the University of Cincinnati shows that direct oral anti-coagulant (DOAC) drugs are more effective and are more cost-effective than low molecular weight heparin (LMWH) for treating cancer-associated thrombosis (CAT). A new study to be published in the Annals of Internal Medicine on December 27, 2022 examines the cost-effectiveness of the four most utilized anticoagulation strategies for blood clots, which include LMWH, apixaban, edoxaban and rivaroxaban. Authors […]

Hospital parking fees contribute to financial toxicity for cancer patients

Transportation to and from cancer centers for outpatient cancer treatments has been identified as one of the two most impactful out-of-pocket costs that cancer patients and their families incur, along with food costs. In an upcoming issue of the Journal of Medical Imaging and Radiation Sciences, published by Elsevier, a team of radiation oncology resident physicians and a biostatistician from the University of […]

Pralsetinib therapy shows high response in range of cancer patients with RET gene fusions

In a Phase I/II trial, cancer treatment with pralsetinib has produced high response rates in patients with RET gene fusions, regardless of tumor type, researchers reported on Aug.12, 2022 in Nature Medicine. “We’ve had an explosion in clinical next-generation sequencing that allows us to understand shared biomarkers across multiple tumor types, and this study was important to determine if RET fusions are […]

Leading radiotherapy researchers identify research priorities to improve outcomes for cancer patients

The NCRI Radiotherapy (CTRad) Group, a world-leading radiotherapy research group, has published its strategic priorities in radiotherapy research to address challenges in the field. The group has identified four strategic priorities it believes need to be addressed by the community to improve outcomes for patients: Translating novel discoveries to and from the clinic Evaluating and optimal implementation of new radiotherapy […]